Company Monitoring Page for Novartis

latest headlines for company on cafepharma

These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
Tags:
FDA, breakthrough therapies, ibrutinib, Pharmacyclics, JNJ, Novartis, LDK378, serelaxin, daratumumab, Genmab
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Fri, 08/30/13 - 09:32 am
Tags:
Novartis, Gilenya, MS, multiple sclerosis, PML, FDA
Novartis discount fails to persuade NICE on Afinitor in breast cancer
Fierce Pharma
Thu, 08/29/13 - 11:08 am
Tags:
Novartis, NICE, breast cancer, Afinitor
A Closer Look at the Controversial Market Growth of ADHD Treatments
Motley Fool
Wed, 08/28/13 - 04:49 pm
Tags:
ADHD, Shire, Adderall, Strattera, Eli Lilly, JNJ, Novartis, Concerta, Ritalin
Vasella considers his Novartis results worth $78M payout; canceled noncompete deal was replaced with $5.2M exit package
Fierce Pharma
Tue, 08/27/13 - 09:12 am
Tags:
Novartis, executive pay, Daniel Vasella
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
Tags:
FDA, breakthrough therapies, AbbVie, Alexion, Ariad Pharmaceuticals, Biomarin, Bristol-Myers Squibb, SynaGeva BioPharma, GSK, JNJ, Merck, Novartis, Pharmacyclics, Pfizer, Vertex Pharmaceuticals, daratumumab, ibrutinib, Kalydeco, lambrolizumab, palbociclib, LDK378, SD-101, obinutuzumab, serelaxin, asfotase alfa, bimagrumab, drisapersen, sebelipase alfa
This Week in Biotech
Motley Fool
Sun, 08/25/13 - 11:27 am
Tags:
Supernus Pharmaceuticals, Novartis, Pain Therapeutics, GTx
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 08/24/13 - 11:46 am
Tags:
Incyte, Novartis, Astex, Pacific Biosciences
"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wed, 08/21/13 - 09:05 am
Tags:
Novartis, breakthrough therapies, BYM338, sporadic inclusion body myositis, FDA
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
Tags:
JNJ, Novartis, Pfizer, Merck, Roche, Bayer, Sanofi, GSK, Abbott Labs, AstraZeneca, Eli Lilly
Avanir, Sandoz settle Nuedexta patent litigation
Pharmaceutical Business Review
Fri, 08/16/13 - 10:55 am
Tags:
Avanir, Sanzoz, patents, generics, Novartis, Nuedexta
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thu, 08/15/13 - 11:48 am
Tags:
Novartis, M&A, Biomarin, Incyte
Novartis to Review Business as Reinhardt Becomes Chairman, Would Consider a $10 Billion Purchase
Bloomberg
Wed, 08/14/13 - 10:21 am
Tags:
Novartis, Joerg Reinhardt, M&A
Novartis, Pfizer Said to Be Out of Bidding for Onyx
Bloomberg
Wed, 08/14/13 - 10:19 am
Tags:
Novartis, Pfizer, ONYX Pharmaceuticals, Amgen, M&A
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wed, 08/14/13 - 10:16 am
Tags:
Receptos, Novartis, Gilenya, MS, multiple sclerosis, RPC1063
China to launch fresh pharmaceutical bribery probe
Yahoo/Reuters
Wed, 08/14/13 - 09:32 am
Tags:
China, Novartis
Report: Novartis Bails on Onyx Bid
Barron's
Tue, 08/13/13 - 04:06 pm
Tags:
Novartis, ONYX Pharmaceuticals, M&A
Why Is Novartis in Trouble in Japan?
Wall St. Cheat Sheet
Tue, 08/13/13 - 10:47 am
Tags:
Japan, Novartis, Diovan
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D, AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer, Regeneron, Roche, Shire, Takeda
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Fri, 08/9/13 - 04:57 pm
Tags:
earnings, Regeneron, Eylea, Amgen, Novartis, Pfizer, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.